Cargando…
Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study
BACKGROUND: Anti-tuberculosis therapy requires at least six-month treatment with continuous administration of combined antibiotics, including isoniazid, rifampicin, pyrazinamide, and ethambutol. The long-term exposure to antibiotics could cause consequent changes in gut microbiota, which may alter t...
Autores principales: | Shi, Wenpei, Hu, Yi, Zheng, Xubin, Ning, Zhu, Wu, Meiying, Xia, Fan, Prast-Nielsen, Stefanie, Hu, Yue O. O., Xu, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849301/ https://www.ncbi.nlm.nih.gov/pubmed/31711450 http://dx.doi.org/10.1186/s12890-019-0981-9 |
Ejemplares similares
-
The gut microbiome and epilepsy
por: Dahlin, Maria, et al.
Publicado: (2019) -
The gut microbiome: A line of defense against tuberculosis development
por: Yu, Ziqi, et al.
Publicado: (2023) -
Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study
por: Miguens Blanco, Jesus, et al.
Publicado: (2020) -
Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol
por: Myers, Bronwyn, et al.
Publicado: (2018) -
Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
por: Yoon, Hyuk, et al.
Publicado: (2022)